To investigate whether myocardial ischaemia elicitable during pharmacological stress echocardiography portends different prognosis in men and women.
Introduction
Sex-based differences have been described in the incidence, clinical presentation, management and prognosis of coronary artery disease (CAD). In particular, a worse clinical outcome has been reported in men with not established [1] [2] [3] or in women with proven CAD, such as after myocardial infarction [3] [4] [5] [6] [7] and coronary artery bypass grafting [8] or in the case of an abnormal scan result [9] . Pharmacological stress echocardiography is an accurate [10] and equal opportunity method for detecting CAD [11, 12] and for assessing prognosis in men and women with known or suspected CAD [13] [14] [15] [16] [17] [18] [19] [20] . However, its prognostic implication in the two sexes remains unknown.
The purpose of this study was to investigate whether myocardial ischaemia induced by pharmacological stress echocardiography is predictive of a different clinical outcome in men and women.
Methods

Patients
The initial population consisted of 1890 patients undergoing pharmacological stress echocardiography for evaluation of known or suspected CAD at two different institutions between November 1990 and December 1997. Ninety patients with history of coronary revascularization and 67 patients with no available follow-up data were excluded. The remaining 1733 patients (941 men, 792 women) represented the study group. Of them, 1008 underwent dipyridamole and 725 dobutamine stress echocardiography. Antianginal medications were discontinued ( -blockers for at least 48 h and longacting nitrates or calcium antagonists for at least 24 h) before testing in 1560 (90%) patients, whilst 173 (10%) patients (97 men and 76 women; P=0·62) were on -blockers (n=55), calcium antagonists (n=112), or nitrates (n=120).
Stress Protocols
Dipyridamole was given intravenously according to the high dose protocol (up to 0·84 mg . kg 1 over 10 min) [21] . Dobutamine was administered using an infusion pump in steps of 3 min each with an initial dose of 5 g . kg . min 1 , up to 40 g . kg . min as a maximum [22] . Starting in April 1993, the two protocols were modified with the coadministration of atropine (up to 1 mg), if no signs of ischaemia were detected and the heart rate was <85% of the age-and sex-predicted maximum at the end of drug infusion [23, 24] . Two-dimensional echocardiogram and 12-lead electrocardiogram were continuously monitored during drug administration and until the heart rate had returned to baseline values 10% during recovery. Cuff blood pressure and electrocardiogram were recorded each minute.
Echocardiographic Analysis
Echocardiographic images were recorded on VHS videotape or digitally stored on magneto-optical disk for subsequent analysis. Two independent observers evaluated images. In case of disagreement, a third observer evaluated the images, and its judgement was binding. Regional wall motion was semiquantitatively assessed with a 16-segment model of the left ventricle [25] . A 4-point score was assigned to each segment as follows: 1=normal, 2=hypokinesia, 3=akinesia, and 4= dyskinesia. A wall motion score index (WMSI), obtained by dividing the sum of individual segment scores by the number of segments considered, was calculated both at baseline and at the peak of drug infusion.
The criteria for ischaemia were new wall motion abnormalities or worsening of pre-existing ones, or a 'biphasic' response (improvement of function at low dose followed by deterioration of function at high dose) [26] . In patients with akinesia at rest, dyskinesia during stress was not considered to indicate ischaemia [27] . Criteria for test interruption were the onset of obvious new wall motion abnormalities, severe chest pain, horizontal or downsloping ST-segment depression d2 mm, ST-segment elevation d1·5 mm, systolic blood pressure >220 mmHg, diastolic blood pressure >120 mmHg, reduction in systolic blood pressure d30 mmHg, supraventricular or ventricular tachyarrythmias and untolerable symptoms. Intravenous aminophylline (up to 240 mg) and metoprolol (up to 5 mg) were at hands as antagonists.
Electrocardiographic Analysis
Ischaemic electrocardiographic (ECG) changes were horizontal or downsloping ST-segment depression or elevation d0·1 mV from baseline at 80 ms after the J point in at least two contiguous non Q-wave leads. In the case of right bundle branch block, ST-segment shift was considered as significant when occurring in leads V 5 and V 6 [28] . ECG changes were considered non-diagnostic in the case of left bundle-branch block, pre-existing ST-segment depression d0·1 mV, paced rhythm and digoxin or antiarrhythmic therapy.
Coronary Angiography
Significant CAD was defined as visually assessed d70% reduction of the luminal diameter of any of the three coronary arteries or their major branches, or d50% reduction of the luminal diameter of the left main coronary artery. Two independent observers, who were unaware of the results of stress echocardiography, reviewed all angiograms.
Follow-up Data
Follow-up data were obtained by review of the patient's hospital records, communication with the patient's physician, review of the patient's chart, telephone interview with the patient conducted by trained personnel, or patient visits to the staff physician at regular interval in the outpatient clinic. The clinical events recorded during the follow-up were cardiac and noncardiac deaths, non-fatal myocardial infarction, and coronary revascularization procedures (surgery or angioplasty).
Deaths from life-threatening arrhythmias, cardiac arrest, congestive heart failure, or myocardial infarction were considered to be cardiac-related, as was sudden and unexpected death outside the hospital. Myocardial infarction was defined on the basis of symptoms, ECG changes and cardiac enzyme level increase.
variables. Survival free of cardiac events was estimated with Kaplan-Meier curves. For survival analysis, only one event was considered in each patient; patients who underwent coronary revascularization or who died of non-cardiac causes were censored at the time of the event. Survival curves were compared with the log-rank test. The associations of selected variables with outcome were assessed with Cox proportional hazard models using univariate and stepwise multivariate procedures. Statistical Package for the Social Sciences (SPSS, Chicago, Illinois, U.S.A.) was used. Hazard ratios (HR) with 95% confidence intervals (CI) were estimated. The following covariates were analysed: sex, age (d65 years), history of myocardial infarction, hypertension, hypercholesterolaemia, diabetes, resting WMSI, stress protocol (dobutamine vs. dipyridamole), WMSI at peak of stress, WMSI (i.e. the variation of WMSI from resting condition to peak of stress, representing an integrated estimation of the extent and severity of wall motion abnormalities), and ECG changes during test. A value of P<0·05 was taken as predetermined level of significance.
Results
Stress Testing, Clinical, and Angiographic Data
An ischaemic response was found in 460 patients (308 men, 152 women), of whom 257 had known and 203 suspected CAD. Clinical, echocardiographic and angiographic data of men and women with and without inducible ischaemia are shown in Table 1 .
Among those with ischaemic response, women were older and more likely to have hypertension and hypercholesterolaemia whilst men were more likely to have a history of previous infarction and higher resting WMSI (Table 1) . No difference in age and risk factors was evident in the subgroup with suspected CAD between the two sexes ( Table 2) . Although women underwent fewer diagnostic procedures than men, the angiographic findings did not differ significantly (Table 1 and 2). Likewise, among those with non-ischaemic response women were older and more likely to have hypertension, whilst men had higher resting WMSI, higher incidence of infarction and multivessel CAD (Table 1) .
Outcomes
During follow-up (25 24 months for the ischaemic and 37 25 months for the non-ischaemic population), 113 cardiac events (45 deaths and 68 infarctions) and 232 coronary revascularizations were observed (Table 3) . Moreover, 24 patients died for non-cardiac reasons.
Revascularization rate in ischaemic population was similar in both sexes (P=0·36) (Fig. 1) . Moreover, men and women undergoing revascularization were comparable as for mult-vessel CAD (75% vs 78%; P=0·68), and WMSI (0·32 0·19 vs 0·34 0·21; P=0·57).
Survival Analysis
Female gender, resting WMSI, age d65 years, WMSI at peak of stress, and WMSI were univariate predictors of the combined end-point of cardiac death and myocardial infarction in the ischaemic group (Table 4) . Cox analysis showed prognosis to be independently related to resting WMSI (HR=2·7, 95% CI 1·3-3·3; P=0·0050), female gender (HR=2·2, 95% CI 1·2-3·7; P=0·0062), age d65 years (HR=1·9, 95% CI=1·0-3·6; P=0·0427), and WMSI (HR=2·1, 95% CI=1·0-3·7; P=0·0447). However, the female gender (HR=2·7, 95% CI 1·1-6·3; P=0·0233) was the only multivariate prognostic predictor in the subroup of patients with ischaemic response and suspected CAD. Five-year infarction-free survival was 82% in men and 71% in women in the whole ischaemic population (P=0·0041) (Fig. 2) as well as in the ischaemic group with suspected CAD (P=0·0175) (Fig. 3) .
Resting WMSI (HR=6·6, 95% CI 4·1-6·5; P<0·0001), history of myocardial infarction (HR=4·9, 95% CI 3·0-8·3; P<0·0001), male gender (HR=1·8, 95% CI 1·1-3·1; P=0·0232), hypercholesterolaemia (HR=1·8, 95% CI 1·1-3·0; P=0·0245), and diabetes (HR=2·0, 95% CI 1·0-4·0; P=0·0450) were univariate predictors of cardiac events in the non-ischaemic sample. Five-year infarction-free survival was 91% in men and 95% in women (P=0·0212) (Fig. 4) . Resting WMSI (HR=4·8, 95% CI 2·6-8·7; P<0·0001), history of myocardial infarction (HR=2·5, 95% CI 1·4-4·4; P=0·0025), and hypercholesterolaemia (HR=1·8, 95% CI 1·1-3·0; P=0·0300) were independent predictors of outcome at multivariate analysis, whilst gender had no prognostic importance. Abbreviations as in Table 1 .
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Discussion
Wall motion changes during pharmacological stress echocardiography are a specific [10] and genderindependent marker of myocardial ischaemia [11, 12] providing useful prognostic information in patients with proven or suspected CAD [13] [14] [15] [16] [17] [18] [19] [20] . The results of this study demonstrate that the female gender is an independent predictor of cardiac events in patients with ischaemic response to pharmacological stress echocardiography. On the contrary, gender is not a multivariate indicator of unfavourable outcome in patients without stressinduced ischaemia.
Comparison with Previous Studies
Sex-related prognostic differences have been found in patients with CAD. In particular, a higher in-hospital as well as post-discharge mortality has been reported in women as compared to men following acute myocardial infarction [4] [5] [6] [7] in spite of better left ventricular function [6] . In addition, reinfarction rate during the first year after infarction is three times as high in women than in men [4] . Sex-related prognostic differences have also been found after coronary artery bypass surgery, with twice as great postoperative mortality in women even after correction for severity of symptoms and extent of coronary disease [8] . Little is known, however, about the prognostic implication of myocardial ischaemia in the two sexes [9] . Our results, which were not influenced by different use of major therapeutic procedures in the two sexes, are in keeping and reinforce the previous findings in nuclear studies. Hachamovitz et al. [9] found a higher rate of cardiac death and myocardial infarction in women than in men with abnormal nuclear scan. A general underuse of revascularization procedures in women (P=0·04) was reported in this study, but the authors did not specify whether the same sex-related bias was present in the subgroup of patients with abnormal nuclear scan with possible interference on the results.
Greater Risk of Adverse Cardiac Events in Women
The worse clinical outcome of CAD in women remains largely unexplained. Women were older and more likely to have hypertension and hypercholesterolaemia than men in our study. Although female gender had stronger prognostic power than age and risk factors did not affect prognosis, a potential inluence of the sex-related difference in clinical variables on the results cannot be ruled out. However, the independent prognostic value of female gender was confirmed in the group of patients with suspected CAD where men and women had similar clinical characteristic. Of note, 5-year infarction-free survival in the whole population as well as in the group with suspected CAD was comparable in the two sexes (71% and 82%, respectively). These findings support the hypothesis of a gender-related prognostic difference by inducible myocardial ischaemia.
Sex-related differences of potential pathophysiological importance have been described in native as well as in diseased coronary arteries. First, it has been speculated that the smaller diameter of the coronary arteries in women might lower the threshold for coronary occlusion [9] . Furthermore, atherosclerotic plaques are more lipid-filled, rich in macrophages, and less densely fibrous in women [29] . Although the clinical correlates of these findings remain to be established, it is known that lipid-rich plaques are more prone to disruption than fibrous plaques [30] . Finally, since collateral circulation is less developed in women than in men with CAD [31] a milder protective role against the consequences of vessel occlusion could be implied [32] .
Clinical Implications
The results of this study have major implications on the treatment of female patients. Women with CAD undergo cardiac catheterization and revascularization procedures less often than men [33] [34] [35] . This may possibly be due to the assumption of a less specific meaning of chest pain and exercise ECG result in women. However, a sex referral bias is not justified on the basis of the increasing evidence of worse prognosis in women as compared to men with CAD. In addition, pharmacological as well as lifestyle preventive measures should be reinforced in the female population with either manifest CAD or high prevalence of risk factors.
Limitations of the Study
As in all observational studies, the decision to perform further diagnostic procedures was taken by the referring physician on the basis of clinical and stress testing data. As a consequence, women underwent fewer cardiac catheterizations as compared to men. Nevertheless, the rate of coronary revascularization was similar over 5-year follow-up.
Pooled results of dipyridamole and dobutamine stress echocardiography are presented in this study. Indeed, although the two drugs can induce ischaemia by different physiological mechanisms, no significant difference between the two stress protocols was found at Cox analysis, confirming the results of recent studies reporting a similar prognostic value [36] [37] [38] .
As it was not routinely applied [23, 24] at the beginning of this study, atropine co-administration was not used in all patients with possible underscoring of sensitivity. Nevertheless, this limitation affected both sexes in the same way, and therefore it does not represent a significant bias .
Likewise, digital acquisition of images for wall motion analysis was not available in all patients. However, it failed to provide significant diagnostic advantages when compared to visual videotape analysis [39] .
